Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-69

Well they did manage to recruit another 40 odd participants taking total numbers to 222 for the 7 day trial but breaking the numbers down into age groups may have been an afterthought and the only way to demonstrate that there was statistical significance but that it could only be seen in older cohorts with better compliance. ive no idea what number of participants would most likely have been good number to produce more reliable statistics, 300, 400, 500 who knows. The point is that according to commentary on the results the study has achieved its goal to provide regulatory compliance for the new rules uk and it will support expansion into new jurisdictions. Let’s hope the TGA now finally has enough information to support approval here. It is proven safe and effective across all cohorts as a treatment. That claim can be made and that claim does not undermine any government public health that advises vaccination mandate as a number one priority.